To determine whether our findings have potential clinical implications, tissue microarrays (TMA) containing 80 lung adenocarcinoma (LUAD) cases and 79 adjacent normal tissue cases from patients were used to examine the expression of BEX2. The gene discussed is BEX2; the disease is lung adenocarcinoma.